KYMR
Kymera Therapeutics Inc Earnings
$33.69
Earnings Summary
Revenue | $7.39Mn |
Net Profits | $-70.75Mn |
Net Profit Margins | -956.88% |
Kymera Therapeutics Inc’s revenue fell -84.56% since last year same period to $7.39Mn in the Q4 2024. On a quarterly growth basis, Kymera Therapeutics Inc has generated 97.65% jump in its revenue since last 3-months.
Kymera Therapeutics Inc’s net profit fell -392.43% since last year same period to $-70.75Mn in the Q4 2024. On a quarterly growth basis, Kymera Therapeutics Inc has generated -13.23% fall in its net profits since last 3-months.
Kymera Therapeutics Inc’s net profit margin fell -3089.06% since last year same period to -956.88% in the Q4 2024. On a quarterly growth basis, Kymera Therapeutics Inc has generated 42.71% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.73 |
EPS Estimate Current Year | -0.73 |
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.73 - a 7.38% jump from last quarter’s estimates.
Kymera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.73.
Key Ratios
Earning Per Share (EPS) | -0.89 |
Kymera Therapeutics Inc’s earning per share (EPS) fell -256% since last year same period to -0.89 in the Q4 2024. This indicates that the Kymera Therapeutics Inc has generated -256% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-02 | -0.73 | -0.62 | 15.07% |
2025-02-27 | -0.79 | -0.89 | -12.92% |
2024-08-07 | -0.68 | -0.58 | 14.71% |
2024-10-31 | -0.84 | -0.82 | 2.38% |
